Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2005

View Archived Issues

Gedeon Richter and Forest Laboratories collaborate on CNS compounds

Phenoxodiol with docetaxel studied for recurrent ovarian cancer

Bristol-Myers Squibb identifies a new inhibitor of HsEg5, an attractive target for cancer

New anti-TNF immunotherapy from Abgenix

OMX-2: cytostatic agent for brain tumor therapy

Sterix's new anticancer candidates

PRO-140 enters phase Ib study in HIV

Astellas licenses rights for XP-13512 in Asia and Japan

Predix reaches agreement under SPA for PRX-00023

PRX-08066 begins phase Ib study for PAH

Imagenetix launches Celadrin/glucosamine product

Canadian sites to join ADAGIO study of Agilect

PIramed and Genentech collaborate to develop new class of anticancer drugs

ImmuFact IMP-321 studied for metastatic renal cell carcinoma

GlaxoSmithKline updates progress of oncology and supportive care compounds

Lexicon Genetics and Genentech expand drug discovery alliance

Clinical progress of a novel investigational anticancer drug BIBW-2992

FDA Advisory Committee to discuss Daytrana NDA

Procleix West Nile Virus Assay receives FDA approval

Priority review awarded to Taxotere sNDA in gastric cancer

Oncaspar sBLA accepted for review

Prostanoid EP4 receptor agonists emerge from Allergan R&D

Novel diagnostic agents disclosed in recent patents

Recent patents cover novel treatments for anxiety, depression, sleep disorders, etc.

Novel proteasome inhibitor compared to bortezomib against multiple myeloma

Antimitochondrial agent RH-123 offers promise in phase I prostate cancer trial

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...